481 related articles for article (PubMed ID: 17586029)
1. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
Tian Q; Huang J; Zhang Q; Zhao J
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
[TBL] [Abstract][Full Text] [Related]
3. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
[TBL] [Abstract][Full Text] [Related]
4. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.
Honegger A; Schilling D; Bastian S; Sponagel J; Kuryshev V; Sültmann H; Scheffner M; Hoppe-Seyler K; Hoppe-Seyler F
PLoS Pathog; 2015 Mar; 11(3):e1004712. PubMed ID: 25760330
[TBL] [Abstract][Full Text] [Related]
5. Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells.
Hoppe-Seyler K; Herrmann AL; Däschle A; Kuhn BJ; Strobel TD; Lohrey C; Bulkescher J; Krijgsveld J; Hoppe-Seyler F
Int J Cancer; 2021 Sep; 149(5):1137-1149. PubMed ID: 33844847
[TBL] [Abstract][Full Text] [Related]
6. HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.
Yu L; Majerciak V; Lobanov A; Mirza S; Band V; Liu H; Cam M; Hughes SH; Lowy DR; Zheng Z-M
mBio; 2024 May; 15(5):e0072924. PubMed ID: 38624210
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout.
Zhen S; Lu J; Liu YH; Chen W; Li X
Cancer Gene Ther; 2020 Apr; 27(3-4):168-178. PubMed ID: 31455836
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells.
Inturi R; Jemth P
Virology; 2021 Oct; 562():92-102. PubMed ID: 34280810
[TBL] [Abstract][Full Text] [Related]
9. Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
D S P; Chaturvedi PK; Krishnamoorthy D; Seo YS; Thippana M; Park WY
PLoS One; 2022; 17(4):e0266532. PubMed ID: 35421154
[TBL] [Abstract][Full Text] [Related]
10. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
[TBL] [Abstract][Full Text] [Related]
11. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.
Wells SI; Aronow BJ; Wise TM; Williams SS; Couget JA; Howley PM
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7093-8. PubMed ID: 12756294
[TBL] [Abstract][Full Text] [Related]
13. Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells.
Rasi F; Zarredar H; Amini M; Onsori H; Dadashzadeh K; Khanmohammadi M; Vahedi L; Mokhtarzadeh A; Baradaran B; Bannazadeh Baghi H
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3389-3395. PubMed ID: 37898842
[TBL] [Abstract][Full Text] [Related]
14. Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells.
Cheng YX; Chen GT; Yang X; Wang YQ; Hong L
Curr Med Sci; 2018 Apr; 38(2):212-221. PubMed ID: 30074178
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.
Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J
Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.
Shai A; Brake T; Somoza C; Lambert PF
Cancer Res; 2007 Feb; 67(4):1626-35. PubMed ID: 17308103
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.
Shang Q; Wang Y; Fang Y; Wei L; Chen S; Sun Y; Li B; Zhang F; Gu H
J Clin Microbiol; 2011 Jul; 49(7):2656-63. PubMed ID: 21593270
[TBL] [Abstract][Full Text] [Related]
18. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Type 16 Circular RNA Is Barely Detectable for the Claimed Biological Activity.
Yu L; Zheng ZM
mBio; 2022 Feb; 13(1):e0359421. PubMed ID: 35038914
[TBL] [Abstract][Full Text] [Related]
20. [Identification regulatory noncoding RNAs of human papilloma virus type 16 (Papillomaviridae: Alphapapillomavirus: Human papillomavirus) in cervical tumors].
Kisseljova NP; Fedorova MD; Zaikina AE; Elkina NV; Goldobina EE; Elkin DS; Abramov PM; Pavlova LS; Vinokurova SV
Vopr Virusol; 2022 Jul; 67(3):217-226. PubMed ID: 35831964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
